IntoCell, Inc. (KOSDAQ:287840)
South Korea flag South Korea · Delayed Price · Currency is KRW
37,750
-1,750 (-4.43%)
At close: Apr 9, 2026

IntoCell Statistics

Total Valuation

IntoCell has a market cap or net worth of KRW 567.08 billion. The enterprise value is 546.49 billion.

Market Cap567.08B
Enterprise Value 546.49B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

IntoCell has 15.02 million shares outstanding. The number of shares has increased by 8.69% in one year.

Current Share Class 15.02M
Shares Outstanding 15.02M
Shares Change (YoY) +8.69%
Shares Change (QoQ) +0.39%
Owned by Insiders (%) 21.65%
Owned by Institutions (%) 9.46%
Float 11.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 246.65
PB Ratio 22.91
P/TBV Ratio 27.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -51.54
EV / Sales 237.70
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -62.31

Financial Position

The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.41.

Current Ratio 9.71
Quick Ratio 9.67
Debt / Equity 0.41
Debt / EBITDA n/a
Debt / FCF -1.16
Interest Coverage -39.90

Financial Efficiency

Return on equity (ROE) is -65.72% and return on invested capital (ROIC) is -24.50%.

Return on Equity (ROE) -65.72%
Return on Assets (ROA) -19.82%
Return on Invested Capital (ROIC) -24.50%
Return on Capital Employed (ROCE) -27.08%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 46,090.00
200-Day Moving Average 44,496.25
Relative Strength Index (RSI) 40.71
Average Volume (20 Days) 87,075

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, IntoCell had revenue of KRW 2.30 billion and -10.60 billion in losses. Loss per share was -744.00.

Revenue2.30B
Gross Profit 2.29B
Operating Income -10.30B
Pretax Income -10.60B
Net Income -10.60B
EBITDA -9.53B
EBIT -10.30B
Loss Per Share -744.00
Full Income Statement

Balance Sheet

The company has 30.80 billion in cash and 10.21 billion in debt, with a net cash position of 20.59 billion or 1,370.40 per share.

Cash & Cash Equivalents 30.80B
Total Debt 10.21B
Net Cash 20.59B
Net Cash Per Share 1,370.40
Equity (Book Value) 24.75B
Book Value Per Share 1,660.40
Working Capital 28.07B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.63 billion and capital expenditures -143.45 million, giving a free cash flow of -8.77 billion.

Operating Cash Flow -8.63B
Capital Expenditures -143.45M
Depreciation & Amortization 774.67M
Net Borrowing -26.02M
Free Cash Flow -8.77B
FCF Per Share -583.80
Full Cash Flow Statement

Margins

Gross Margin 99.65%
Operating Margin -448.01%
Pretax Margin -461.20%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IntoCell does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.69%
Shareholder Yield -8.69%
Earnings Yield -1.87%
FCF Yield -1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IntoCell has an Altman Z-Score of 19.79 and a Piotroski F-Score of 3.

Altman Z-Score 19.79
Piotroski F-Score 3